Vaccination News

Last week, Anthony S. Fauci, MD, announced that he will step down as director of the National Institute of Allergy and Infectious Diseases in December.

Moderna said Friday that it is filing lawsuits against Pfizer and BioNTech alleging that their COVID-19 messenger RNA vaccine infringes on patents crucial to the development of Moderna's mRNA vaccine.

Women born in the 1990s had a significantly lower HPV infection rate compared with those born a decade earlier — a finding that allowed researchers to connect greater HPV vaccination coverage with direct protection and herd immunity.

Pfizer reported Thursday that its vaccine candidate for respiratory syncytial virus was nearly 86% effective in preventing severe illness in a phase 3 clinical trial of older adults.

After requesting emergency use authorization for their omicron-adapted COVID-19 vaccine in people aged 12 years and older, Pfizer and BioNTech said Tuesday they are also working with the FDA on bringing a booster to younger children.

A pediatric typhoid vaccine provided immunity for up to 3 years in children as young as 9 months old, according to a study published in The Lancet Global Health.

The Democratic Republic of the Congo has declared a resurgence of Ebola virus after confirming that a case in North Kivu province was linked to a previous outbreak.

A database analysis showed no association between messenger RNA COVID-19 vaccines and risk for acute MI, stroke or pulmonary embolism, but a slight increase in risk for PE and MI after receiving the AstraZeneca or Janssen vaccines.

The CDC on Monday recommended Novavax’s COVID-19 vaccine for use in adolescents aged 12 to 17 years.

Receiving a booster dose of either the Pfizer-BioNTech or Johnson & Johnson vaccine increased immune responses in people who previously received the Pfizer-BioNTech vaccine.